FDA

FDA Approves Corcept’s Lifyorli™ Combo for Platinum-Resistant Ovarian Cancer

U.S. Food and Drug Administration Approves Corcept’s Lifyorli™ (relacorilant) Combination Therapy for Platinum-Resistant Ovarian Cancer Corcept Therapeutics Incorporated has announced a major regulatory milestone with the approval of its novel therapy, Lifyorli™ (relacorilant), by the U.S. Food and Drug Administration.…

Read MoreFDA Approves Corcept’s Lifyorli™ Combo for Platinum-Resistant Ovarian Cancer

Seaport Therapeutics Publishes Science Translational Medicine Study on GlyphAllo™ (SPT-300) Prodrug

PureTech Founded Entity Seaport Therapeutics Publishes First-in-Human Data on GlyphAllo™ (SPT-300) in Science Translational Medicine PureTech Health plc a biotherapeutics company focused on advancing innovative science into impactful medicines, announced that its Founded Entity, Seaport Therapeutics, has published significant clinical…

Read MoreSeaport Therapeutics Publishes Science Translational Medicine Study on GlyphAllo™ (SPT-300) Prodrug
Imperative

Imperative Care Starts CLEAR-IT Study for Peripheral Thromboembolism Standards

Imperative Care Launches CLEAR-IT Study to Advance Standards in Peripheral Thromboembolism Imperative Care, Inc., a medical technology company dedicated to advancing innovative treatments for patients with thromboembolic diseases, has announced a significant milestone in its ongoing clinical research efforts: the…

Read MoreImperative Care Starts CLEAR-IT Study for Peripheral Thromboembolism Standards
Emagine

Emagine Solutions Secures ACA Grant, Opens Arizona Maternal Health Study Applications

Emagine Solutions Technology Secures ACA Grant, Launches Applications for Arizona Maternal Health Study Emagine Solutions Technology, a company focused on advancing maternal health through innovative digital and wearable solutions, has announced that it has been awarded a significant $250,000 grant…

Read MoreEmagine Solutions Secures ACA Grant, Opens Arizona Maternal Health Study Applications
Artesia

Artesia General Hospital Introduces Ambient AI to Strengthen Patient-Physician Connections Rural Care

Artesia General Hospital Leverages Ambient AI to Transform Rural Healthcare Delivery ARTESIA,General Hospital (AGH), a leading healthcare provider serving southeastern New Mexico, is taking a major step forward in modernizing rural healthcare by implementing advanced ambient artificial intelligence technology. In…

Read MoreArtesia General Hospital Introduces Ambient AI to Strengthen Patient-Physician Connections Rural Care
Biocytogen

Biocytogen, Moonlight Bio Partner to Advance Cell Therapies with Antibody Library

Biocytogen Partners with Moonlight Bio to Advance Cell Therapies Through Antibody Library Collaboration Biocytogen Pharmaceuticals (Beijing) a globally recognized biotechnology company, has announced a strategic collaboration with Moonlight Bio, Inc., a Seattle-based innovator in advanced cell therapy development. This partnership…

Read MoreBiocytogen, Moonlight Bio Partner to Advance Cell Therapies with Antibody Library